全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
PLOS ONE  2012 

A Screen for Selective Killing of Cells with Chromosomal Instability Induced by a Spindle Checkpoint Defect

DOI: 10.1371/journal.pone.0047447

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background The spindle assembly checkpoint is crucial for the maintenance of a stable chromosome number. Defects in the checkpoint lead to Chromosomal INstability (CIN), which is linked to the progression of tumors with poor clinical outcomes such as drug resistance and metastasis. As CIN is not found in normal cells, it offers a cancer-specific target for therapy, which may be particularly valuable because CIN is common in advanced tumours that are resistant to conventional therapy. Principal Findings Here we identify genes that are required for the viability of cells with a CIN phenotype. We have used RNAi knockdown of the spindle assembly checkpoint to induce CIN in Drosophila and then screened the set of kinase and phosphatase genes by RNAi knockdown to identify those that induce apoptosis only in the CIN cells. Genes identified include those involved in JNK signaling pathways and mitotic cytoskeletal regulation. Conclusions/Significance The screen demonstrates that it is feasible to selectively kill cells with CIN induced by spindle checkpoint defects. It has identified candidates that are currently being pursued as cancer therapy targets (e.g. Nek2: NIMA related kinase 2), confirming that the screen is able to identify promising drug targets of clinical significance. In addition, several other candidates were identified that have no previous connection with mitosis or apoptosis. Further screening and detailed characterization of the candidates could potentially lead to the therapies that specifically target advanced cancers that exhibit CIN.

References

[1]  Mertens F, Johansson B, Mitelman F (1994) Isochromosomes in neoplasia. Genes, Chromosomes and Cancer 10: 221–230.
[2]  Gao C, Furge K, Koeman J, Dykema K, Su Y, et al. (2007) Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations. Proceedings of the National Academy of Sciences 104: 8995–9000.
[3]  Heilig CE, L?ffler H, Mahlknecht U, Janssen JWG, Ho AD, et al. (2009) Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk group. Journal of Cellular and Molecular Medicine 14: 895–902.
[4]  Swanton C, Nicke B, Schuett M, Eklund AC, Ng C, et al. (2009) Chromosomal instability determines taxane response. Proceedings of the National Academy of Sciences 106: 8671–8676.
[5]  Sotillo R, Schvartzman J-M, Socci ND, Benezra R (2010) Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature 464: 436–440.
[6]  Jallepalli PV, Waizenegger IC, Bunz F, Langer S, Speicher MR, et al. (2001) Securin Is Required for Chromosomal Stability in Human Cells. Cell 105: 445–457.
[7]  Thompson SL, Compton DA (2008) Examining the link between chromosomal instability and aneuploidy in human cells. The Journal of Cell Biology 180: 665–672.
[8]  Fukasawa K, Vande Woude GF (1997) Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Molecular and Cellular Biology 17: 506–518.
[9]  Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L, et al. (2001) Centrosome Defects Can Account for Cellular and Genetic Changes That Characterize Prostate Cancer Progression. Cancer Research 61: 2212–2219.
[10]  Weaver BA, Cleveland DW (2006) Does aneuploidy cause cancer? Curr Opin Cell Biol 18: 658–667.
[11]  Thompson SL, Bakhoum SF, Compton DA (2010) Mechanisms of Chromosomal Instability. Current biology: CB 20: R285–R295.
[12]  Musacchio A, Salmon ED (2007) The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8: 379–393.
[13]  Rieder CL, Maiato H (2004) Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell 7: 637–651.
[14]  Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JKV, et al. (1998) Mutations of mitotic checkpoint genes in human cancers. Nature 392: 300–303.
[15]  Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, et al. (2001) MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409: 355–359.
[16]  Hanks S, Coleman K, Reid S, Plaja A, Firth H, et al. (2004) Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 36: 1159–1161.
[17]  Schvartzman J-M, Sotillo R, Benezra R (2010) Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer 10: 102–115.
[18]  Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. (2007) The Genomic Landscapes of Human Breast and Colorectal Cancers. Science 318: 1108–1113.
[19]  Cimini D, Howell B, Maddox P, Khodjakov A, Degrassi F, et al. (2001) Merotelic Kinetochore Orientation Is a Major Mechanism of Aneuploidy in Mitotic Mammalian Tissue Cells. The Journal of Cell Biology 153: 517–528.
[20]  Hollstein M, Sidransky D, Vogelstein B, Harris C (1991) p53 mutations in human cancers. Science 253: 49–53.
[21]  Burds AA, Lutum AS, Sorger PK (2005) Generating chromosome instability through the simultaneous deletion of Mad2 and p53. Proceedings of the National Academy of Sciences of the United States of America 102: 11296–11301.
[22]  Kasiappan R, Shih H-J, Chu K-L, Chen W-T, Liu H-P, et al. (2009) Loss of p53 and MCT-1 Overexpression Synergistically Promote Chromosome Instability and Tumorigenicity. Molecular Cancer Research 7: 536–548.
[23]  Yunis J (1983) The chromosomal basis of human neoplasia. Science 221: 227–236.
[24]  Mitelman F, Johansson B, Mandahl N, Mertens F (1997) Clinical significance of cytogenetic findings in solid tumors. Cancer Genetics and Cytogenetics 95: 1–8.
[25]  Buffin E, Emre D, Karess RE (2007) Flies without a spindle checkpoint. Nat Cell Biol 9: 565–572.
[26]  Prencipe M, McGoldrick A, Perry AS, O’Grady A, Phelan S, et al. (2010) MAD2 downregulation in hypoxia is independent of promoter hypermethylation. Cell Cycle 9: 2856–2865.
[27]  Furlong F, Fitzpatrick P, O’Toole S, Phelan S, McGrogan B, et al. (2012) Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer. The Journal of Pathology 226: 746–755.
[28]  Zhang J, Neisa R, Mao Y (2009) Oncogenic Adenomatous Polyposis Coli Mutants Impair the Mitotic Checkpoint through Direct Interaction with Mad2. Molecular Biology of the Cell 20: 2381–2388.
[29]  Dikovskaya D, Schiffmann D, Newton IP, Oakley A, Kroboth K, et al. (2007) Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis. The Journal of Cell Biology 176: 183–195.
[30]  Draviam VM, Shapiro I, Aldridge B, Sorger PK (2006) Misorientation and reduced stretching of aligned sister kinetochores promote chromosome missegregation in EB1- or APC-depleted cells. EMBO J 25: 2814–2827.
[31]  Hunter T (2000) Signaling–2000 and Beyond. Cell 100: 113–127.
[32]  Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411: 355–365.
[33]  Zhang J, Yang PL, Gray NS (2009) Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 9: 28–39.
[34]  Suzuki K, Kokuryo T, Senga T, Yokoyama Y, Nagino M, et al. (2010) Novel combination treatment for colorectal cancer using Nek2 siRNA and cisplatin. Cancer Science 101: 1163–1169.
[35]  Weaver BAA, Cleveland DW (2009) The role of aneuploidy in promoting and suppressing tumors. The Journal of Cell Biology 185: 935–937.
[36]  Janssen A, Kops GJPL, Medema RH (2009) Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells. Proceedings of the National Academy of Sciences 106: 19108–19113.
[37]  Mills KD, Ferguson DO, Alt FW (2003) The role of DNA breaks in genomic instability and tumorigenesis. Immunological Reviews 194: 77–95.
[38]  Kaye JA, Melo JA, Cheung SK, Vaze MB, Haber JE, et al. (2004) DNA Breaks Promote Genomic Instability by Impeding Proper Chromosome Segregation. Current Biology 14: 2096–2106.
[39]  Orr B, Bousbaa H, Sunkel CE (2007) Mad2-independent Spindle Assembly Checkpoint Activation and Controlled Metaphase–Anaphase Transition in Drosophila S2 Cells. Molecular Biology of the Cell 18: 850–863.
[40]  Roschke AV, Kirsch IR (2005) Targeting Cancer Cells by Exploiting Karyotypic Complexity and Chromosomal Instability. Cell Cycle 4: 679–682.
[41]  Duensing A, Duensing S (2010) Centrosomes, polyploidy and cancer. Adv Exp Med Biol 676: 93–103.
[42]  Mazzorana M, Montoya G, B. Mortuza G (2011) The Centrosome: A Target for Cancer Therapy. Current Cancer Drug Targets 11: 600–612.
[43]  Galimberti F, Thompson SL, Ravi S, Compton DA, Dmitrovsky E (2011) Anaphase Catastrophe Is a Target for Cancer Therapy. Clinical Cancer Research 17: 1218–1222.
[44]  Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537–549.
[45]  McEwen DG, Peifer M (2005) Puckered, a Drosophila MAPK phosphatase, ensures cell viability by antagonizing JNK-induced apoptosis. Development 132: 3935–3946.
[46]  Gutierrez GJ, Tsuji T, Cross JV, Davis RJ, Templeton DJ, et al. (2010) JNK-mediated Phosphorylation of Cdc25C Regulates Cell Cycle Entry and G2/M DNA Damage Checkpoint. Journal of Biological Chemistry 285: 14217–14228.
[47]  Wakefield JG, Bonaccorsi S, Gatti M (2001) The Drosophila Protein Asp Is Involved in Microtubule Organization during Spindle Formation and Cytokinesis. The Journal of Cell Biology 153: 637–648.
[48]  Lunardi A, Di Minin G, Provero P, Dal Ferro M, Carotti M, et al. (2010) A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network. Proceedings of the National Academy of Sciences 107: 6322–6327.
[49]  Ma Z, Izumi H, Kanai M, Kabuyama Y, Ahn NG, et al. (2006) Mortalin controls centrosome duplication via modulating centrosomal localization of p53. Oncogene 25: 5377–5390.
[50]  Tritarelli A, Oricchio E, Ciciarello M, Mangiacasale R, Palena A, et al. (2004) p53 Localization at Centrosomes during Mitosis and Postmitotic Checkpoint Are ATM-dependent and Require Serine 15 Phosphorylation. Molecular Biology of the Cell 15: 3751–3757.
[51]  Liu Q, Hirohashi Y, Du X, Greene MI, Wang Q (2010) Nek2 targets the mitotic checkpoint proteins Mad2 and Cdc20: A mechanism for aneuploidy in cancer. Experimental and Molecular Pathology 88: 225–233.
[52]  Schl?fli P, Borter E, Spielmann P, Wenger R (2009) The PAS-domain kinase PASKIN: a new sensor in energy homeostasis. Cellular and Molecular Life Sciences 66: 876–883.
[53]  MacDonald P, Rorsman P (2011) Per-arnt-sim (PAS) domain kinase (PASK) as a regulator of glucagon secretion. Diabetologia 54: 719–721.
[54]  Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, et al.. (2012) DNA breaks and chromosome pulverization from errors in mitosis. Nature advance online publication.
[55]  Dotiwala F, Harrison JC, Jain S, Sugawara N, Haber JE (2010) Mad2 Prolongs DNA Damage Checkpoint Arrest Caused by a Double-Strand Break via a Centromere-Dependent Mechanism. Current Biology 20: 328–332.
[56]  Petitjean A, Achatz MIW, Borresen-Dale AL, Hainaut P, Olivier M (2007) TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 26: 2157–2165.
[57]  Bogoyevitch MA, Arthur PG (2008) Inhibitors of c-Jun N-terminal kinases” JuNK no more? Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics 1784: 76–93.
[58]  Bogoyevitch MA, Ngoei KRW, Zhao TT, Yeap YYC, Ng DCH (2009) c-Jun N-terminal kinase (JNK) signaling: Recent advances and challenges. Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics 1804: 463–475.
[59]  Lawlor KT, O’Keefe LV, Samaraweera SE, van Eyk CL, McLeod CJ, et al. (2011) Double-stranded RNA is pathogenic in Drosophila models of expanded repeat neurodegenerative diseases. Human Molecular Genetics 20: 3757–3768.
[60]  Williams BC, Goldberg ML (1994) Determinants of Drosophila zw10 protein localization and function. Journal of Cell Science 107: 785–798.
[61]  Sonn S, Oh GT, Rhee K (2011) Nek2 and its substrate, centrobin/Nip2, are required for proper meiotic spindle formation of the mouse oocytes. Zygote 19: 15–20.
[62]  Smith J, Mun Tho L, Xu N, A. Gillespie D (2010) The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Advances in Cancer Research. 73–112.
[63]  Stronach B (2005) Dissecting JNK signaling, one KKKinase at a time. Developmental Dynamics 232: 575–584.
[64]  Ishimaru S, Ueda R, Hinohara Y, Ohtani M, Hanafusa H (2004) PVR plays a critical role via JNK activation in thorax closure during Drosophila metamorphosis. EMBO J 23: 3984–3994.
[65]  Polaski S, Whitney L, Barker BW, Stronach B (2006) Genetic Analysis of Slipper/Mixed Lineage Kinase Reveals Requirements in Multiple Jun-N-Terminal Kinase-Dependent Morphogenetic Events During Drosophila Development. Genetics 174: 719–733.
[66]  Liu RX, Wang WQ, Ye L, Bi YF, Fang H, et al. (2010) p21-Activated kinase 3 is overexpressed in thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome and participates in cell migration. Endocrine 38: 38–47.
[67]  Menzel N, Schneeberger D, Raabe T (2007) The Drosophila p21 activated kinase Mbt regulates the actin cytoskeleton and adherens junctions to control photoreceptor cell morphogenesis. Mechanisms of Development 124: 78–90.
[68]  De A (2011) Wnt/Ca2+ signaling pathway: a brief overview. Acta Biochimica et Biophysica Sinica 43: 745–756.
[69]  Moniz S, Jordan P (2010) Emerging roles for WNK kinases in cancer. Cellular and Molecular Life Sciences 67: 1265–1276.
[70]  Aihara H, Nakagawa T, Yasui K, Ohta T, Hirose S, et al. (2004) Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in the early Drosophila embryo. Genes & Development 18: 877–888.
[71]  Kawajiri S, Saiki S, Sato S, Hattori N (2011) Genetic mutations and functions of PINK1. Trends in pharmacological sciences 32: 573–580.
[72]  Shiryaev A, Moens U (2010) Mitogen-activated protein kinase p38 and MK2, MK3 and MK5: Ménage à trois or ménage à quatre? Cellular Signalling 22: 1185–1192.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133